L M Srivastava Selected Research

Apolipoproteins

4/2004	Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.
3/2002	Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L M Srivastava Research Topics

Disease

4	Hyperhomocysteinemia 04/2016 - 01/2002
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2016 - 03/2000
3	Atherosclerosis 03/2016 - 03/2002
2	Vascular Diseases (Vascular Disease) 04/2012 - 01/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2004 - 01/2000
1	Osteoporosis 07/2017
1	Infections 04/2016
1	Inflammation (Inflammations) 04/2016
1	Hearing Loss (Hearing Impairment) 04/2016
1	Thrombosis (Thrombus) 03/2016
1	Iron Deficiencies 11/2015
1	Hypercholesterolemia 04/2006
1	Body Weight (Weight, Body) 04/2006
1	Atherosclerotic Plaque (Atheroma) 04/2006
1	Hypertriglyceridemia 04/2004
1	Pulmonary Tuberculosis 06/2003
1	Dyslipidemias (Dyslipidemia) 03/2002
1	Coronary Disease (Coronary Heart Disease) 03/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2002
1	Myocardial Infarction 05/2000
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 03/2000
1	Glomerulonephritis 01/2000

Drug/Important Bio-Agent (IBA)

3	HomocysteineIBA 04/2012 - 01/2002
2	Lipoprotein(a)IBA 03/2016 - 03/2000
2	oxidized low density lipoproteinIBA 03/2016 - 04/2014
2	Vitamin B Complex (B Vitamins)IBA 04/2012 - 01/2002
2	Free RadicalsIBA 04/2006 - 05/2000
2	LipidsIBA 04/2006 - 03/2002
2	ApolipoproteinsIBA 04/2004 - 03/2002
2	Complement Receptors (Complement Receptor)IBA 01/2004 - 01/2000
2	EnzymesIBA 01/2004 - 01/2002
1	Estrogens (Estrogen)FDA Link 07/2017
1	Matrix Metalloproteinase InhibitorsIBA 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2016
1	Matrix Metalloproteinases (MMPs)IBA 04/2016
1	Metalloproteases (Metalloproteinases)IBA 04/2016
1	Fibrinolysin FDA Link 03/2016
1	IronIBA 11/2015
1	Ferritins (Ferritin)IBA 11/2015
1	Cystatin CIBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2006
1	AntioxidantsIBA 04/2006
1	VitaminsIBA 01/2004
1	Interleukin-2 (IL2)IBA 06/2003
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 06/2003
1	Lipoproteins (Lipoprotein)IBA 03/2002
1	Apolipoproteins E (ApoE)IBA 03/2002
1	Oxidoreductases (Dehydrogenase)IBA 01/2002
1	SulfurIBA 01/2002
1	Methionine (L-Methionine)FDA Link 01/2002
1	Amino Acids FDA Link 01/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2002
1	Oxygen (Dioxygen)IBA 05/2000
1	NitritesIBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000
1	Complement System Proteins (Complement)IBA 01/2000
1	CD59 AntigensIBA 01/2000
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2000